Back
Crinetics Pharmaceuticals, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
1
CRNX
Crinetics Pharmaceuticals, Inc.
Last Price:
$42.65
Seasonality Move:
0.97%
7 Day Trial
ALL ACCESS PASS
$
7
Crinetics Pharmaceuticals, Inc. Stock Forecast
-
Over the next 52 weeks, Crinetics Pharmaceuticals, Inc. has on average historically risen by 12.9% based on the past 7 years of stock performance.
-
Crinetics Pharmaceuticals, Inc. has risen higher in 5 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 71.43%
-
Is Crinetics Pharmaceuticals, Inc. Stock Undervalued?The current Crinetics Pharmaceuticals, Inc. [CRNX] share price is $42.70. The Score for CRNX is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
-
CRNX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
Will Crinetics Pharmaceuticals, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Crinetics Pharmaceuticals, Inc. has on average historically risen by 12.9% based on the past 7 years of stock performance.
Crinetics Pharmaceuticals, Inc. Stock Rating
Sell
1
Crinetics Pharmaceuticals, Inc. (CRNX)
is a Sell
Is Crinetics Pharmaceuticals, Inc. overpriced?
-
Crinetics Pharmaceuticals, Inc. has risen higher in 5 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 71.43%
Crinetics Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
crinetics.com
52-Week Data
52-Week High:
57.99
52-Week Low:
24.10
Prediction Charts
Market Cap:
4.4B
Price in USD:
42.70
Volume:
1.4M
Beta:
0.68
Technical Analysis
SMA50:
49.60
SMA100:
46.08
SMA200:
38.66
52-Wk Change:
21.1%
Stock Predictions
-
Is Crinetics Pharmaceuticals, Inc. stock public?Yes, Crinetics Pharmaceuticals, Inc. is a publicly traded company.
-
What is the Crinetics Pharmaceuticals, Inc. stock quote today?The Crinetics Pharmaceuticals, Inc. stock price is 42.70 USD today.
-
How to buy Crinetics Pharmaceuticals, Inc. stock online?You can buy Crinetics Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-27 | 52.57 | 52.97 | 53.27 | 51.77 |
| Jan-28 | 53.16 | 51.32 | 53.60 | 50.84 |
| Jan-29 | 50.97 | 51.88 | 52.72 | 50.97 |
| Jan-30 | 52.28 | 49.94 | 52.95 | 49.31 |
| Feb-2 | 49.26 | 49.35 | 50.43 | 48.79 |
| Feb-3 | 49.35 | 49.96 | 50.57 | 48.54 |
| Feb-4 | 50.04 | 47.43 | 50.15 | 46.56 |
| Feb-5 | 47.42 | 44.79 | 48.00 | 44.48 |
| Feb-6 | 45.94 | 45.28 | 46.66 | 43.94 |
| Feb-9 | 45.27 | 46.01 | 46.24 | 44.20 |
| Feb-10 | 46.07 | 47.61 | 48.44 | 45.74 |
| Feb-11 | 48.27 | 47.61 | 48.58 | 46.48 |
| Feb-12 | 48.41 | 44.08 | 48.41 | 44.02 |
| Feb-13 | 44.01 | 42.70 | 45.05 | 41.97 |
Crinetics Pharmaceuticals, Inc. Earnings
Crinetics Pharmaceuticals, Inc. Earnings Report: Per Share Crinetics Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Crinetics Pharmaceuticals, Inc. Forecast Revenue Growth
Crinetics Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Crinetics Pharmaceuticals, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and an increase next year of $1.50 per share.
* Crinetics Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.